E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/5/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Nanopierce completes $1.5 million convertible preferred offering

By Sheri Kasprzak

New York, Oct. 5 - Nanopierce Technologies, Inc. said it raised $1.5 million from a private placement of convertible preferred stock and is arranging another convertible preferred offering.

The company sold 200,000 shares of series A convertible preferred stock at $7.50 each to Arizcan Properties, Ltd.

The 8% preferreds are convertible into 60% of the company's outstanding, post-split common shares. As of Oct. 3, the company had 133,059,033 outstanding common shares.

The terms of the second offering have not yet been determined, but the deal is set to close during fiscal year 2006. The proceeds will be used to support operations.

Based in Denver, Nanopierce is a biotechnology company.

Issuer:Nanopierce Technologies, Inc.
Issue:Series A convertible preferred stock
Amount:$1.5 million
Shares:200,000
Price:$7.50
Dividends:8%
Conversion ratio:Into 60% of the company's outstanding common shares
Warrants:No
Investor:Arizcan Properties Ltd.
Settlement date:Sept. 26
Stock price:$0.09 at close Sept. 26

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.